• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五大洲的癌症发病率、死亡率和患病率模式:确定在世界不同地理区域减少癌症差异的优先事项。

Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World.

机构信息

From the Nutritional Epidemiology and Biostatistics Branches, Division of Cancer Epidemiology and Genetics; Office of Preventive Oncology, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services.

出版信息

J Clin Oncol. 2023 Dec 1;41(34):5209-5224. doi: 10.1200/JCO.23.00864.

DOI:10.1200/JCO.23.00864
PMID:38016281
Abstract

Efforts to reduce global cancer disparities begin with an understanding of geographic patterns in cancer incidence, mortality, and prevalence. Using the GLOBOCAN (2002) and Cancer Incidence in Five Continents databases, we describe overall cancer incidence, mortality, and prevalence, age-adjusted temporal trends, and age-specific incidence patterns in selected geographic regions of the world. For the eight most common malignancies-cancers of lung, breast, colon and rectum, stomach, prostate, liver, cervix, and esophagus-the most important risk factors, cancer prevention and control measures are briefly reviewed.In 2002, an estimated 11 million new cancer cases and 7 million cancer deaths were reported worldwide; nearly 25 million persons were living with cancer. Among the eight most common cancers, global disparities in cancer incidence, mortality, and prevalence are evident, likely due to complex interactions of nonmodifiable (ie, genetic susceptibility and aging) and modifiable risk factors (ie, tobacco, infectious agents, diet, and physical activity). Indeed, when risk factors among populations are intertwined with differences in individual behaviors, cultural beliefs and practices, socioeconomic conditions, and health care systems, global cancer disparities are inevitable. For the eight most common cancers, priorities for reducing cancer disparities are discussed.

摘要

要减少全球癌症的差距,首先需要了解癌症发病率、死亡率和流行率的地理分布模式。我们利用 GLOBOCAN(2002 年)和《五大洲癌症发病率》数据库,描述了全球部分特定地区的总体癌症发病率、死亡率和流行率、年龄调整后的时间趋势以及特定年龄的发病模式。对于肺癌、乳腺癌、结肠癌和直肠癌、胃癌、前列腺癌、肝癌、宫颈癌和食管癌这 8 种最常见的恶性肿瘤,简要回顾了主要的危险因素和癌症的预防控制措施。2002 年,全球估计有 1100 万例新发癌症病例和 700 万例癌症死亡病例;约有 2500 万人患有癌症。在这 8 种最常见的癌症中,癌症的发病率、死亡率和流行率存在明显的全球差距,这可能是由于不可改变的(即遗传易感性和衰老)和可改变的危险因素(即烟草、感染因子、饮食和体力活动)之间复杂的相互作用所致。事实上,当人群中的危险因素与个人行为、文化信仰和习俗、社会经济条件以及医疗保健系统的差异交织在一起时,全球癌症差距是不可避免的。对于这 8 种最常见的癌症,我们讨论了减少癌症差距的优先事项。

相似文献

1
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World.五大洲的癌症发病率、死亡率和患病率模式:确定在世界不同地理区域减少癌症差异的优先事项。
J Clin Oncol. 2023 Dec 1;41(34):5209-5224. doi: 10.1200/JCO.23.00864.
2
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.五大洲癌症发病率、死亡率及患病率模式:确定全球不同地理区域减少癌症差异的优先事项。
J Clin Oncol. 2006 May 10;24(14):2137-50. doi: 10.1200/JCO.2005.05.2308.
3
Global Burden of 5 Major Types of Gastrointestinal Cancer.全球 5 大常见胃肠道癌症负担
Gastroenterology. 2020 Jul;159(1):335-349.e15. doi: 10.1053/j.gastro.2020.02.068. Epub 2020 Apr 2.
4
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
5
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.全球癌症发病趋势与人类发展指数(2008-2030 年):基于人群的研究。
Lancet Oncol. 2012 Aug;13(8):790-801. doi: 10.1016/S1470-2045(12)70211-5. Epub 2012 Jun 1.
6
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 32 种癌症组别的伤残调整生命年数,1990 年至 2015 年:全球疾病负担研究的系统分析。
JAMA Oncol. 2017 Apr 1;3(4):524-548. doi: 10.1001/jamaoncol.2016.5688.
7
Recent Mortality Patterns and Time Trends for the Major Cancers in 47 Countries Worldwide.全球 47 个国家主要癌症的近期死亡率模式和时间趋势。
Cancer Epidemiol Biomarkers Prev. 2023 Jul 5;32(7):894-905. doi: 10.1158/1055-9965.EPI-22-1133.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016.印度各邦癌症负担及其变化:1990-2016 年全球疾病负担研究。
Lancet Oncol. 2018 Oct;19(10):1289-1306. doi: 10.1016/S1470-2045(18)30447-9. Epub 2018 Sep 12.
10
Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study.1990 - 2019年亚洲癌症负担的时间模式:针对《2019年全球疾病负担研究》的系统分析
Lancet Reg Health Southeast Asia. 2024 Jan 2;21:100333. doi: 10.1016/j.lansea.2023.100333. eCollection 2024 Feb.

引用本文的文献

1
UBE2C: a potential therapeutic target and prognostic biomarker for prostate cancer patients.UBE2C:前列腺癌患者潜在的治疗靶点和预后生物标志物。
Funct Integr Genomics. 2025 Jul 25;25(1):159. doi: 10.1007/s10142-025-01671-5.
2
CeO nanozyme-embedded thermal-deformative polymer for site-specific chemotherapy via HIF-1α-P-gp/lipolysis axis reversal.通过HIF-1α-P-gp/脂解轴逆转实现位点特异性化疗的二氧化铈纳米酶嵌入热变形聚合物
Asian J Pharm Sci. 2025 Jun;20(3):101023. doi: 10.1016/j.ajps.2025.101023. Epub 2025 Jan 31.
3
Uncertainties in outcome modelling in radiation oncology.
放射肿瘤学中结果建模的不确定性。
Phys Imaging Radiat Oncol. 2025 May 7;34:100774. doi: 10.1016/j.phro.2025.100774. eCollection 2025 Apr.
4
Global, Regional, and National Burden of Breast Cancer, 1990-2021, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家乳腺癌负担及到2050年的预测:全球疾病负担研究2021的系统分析
Thorac Cancer. 2025 May;16(9):e70052. doi: 10.1111/1759-7714.70052.
5
Impact of (poly)phenol-rich dietary sources on DNA damage: insights from human intervention studies using the Comet assay - a review and perspective.富含(多)酚类的饮食来源对DNA损伤的影响:使用彗星试验的人体干预研究的见解——综述与展望
Br J Nutr. 2025 Jul 14;134(1):1-15. doi: 10.1017/S000711452500073X. Epub 2025 Apr 7.
6
SOAT1 Activates NLRP3 Inflammasome to Promote Cancer-Related Lymphangiogenesis and Metastasis via IL-1β/IL-1R-1 Axis in Oral Squamous Cell Carcinoma.SOAT1通过IL-1β/IL-1R-1轴激活NLRP3炎性小体,促进口腔鳞状细胞癌中与癌症相关的淋巴管生成和转移。
Mol Carcinog. 2025 Jun;64(6):1039-1056. doi: 10.1002/mc.23907. Epub 2025 Mar 26.
7
TRAF3IP3 Induces ER Stress-Mediated Apoptosis with Protective Autophagy to Inhibit Lung Adenocarcinoma Proliferation.TRAF3IP3通过保护性自噬诱导内质网应激介导的细胞凋亡以抑制肺腺癌增殖。
Adv Sci (Weinh). 2025 May;12(17):e2411020. doi: 10.1002/advs.202411020. Epub 2025 Mar 11.
8
Early report on abbreviated brachytherapy schema for cervical cancer during the COVID-19 pandemic.2019冠状病毒病大流行期间宫颈癌简化近距离放射治疗方案的早期报告。
J Contemp Brachytherapy. 2024 Dec;16(6):437-442. doi: 10.5114/jcb.2024.146515. Epub 2024 Dec 31.
9
Global, Regional, and National Burden of Male Breast Cancer, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021.1990 - 2021年全球、区域和国家男性乳腺癌负担:全球疾病负担研究2021的系统分析
Cancer Med. 2025 Feb;14(3):e70632. doi: 10.1002/cam4.70632.
10
Sensitivity of major chronic diseases and patients of different ages to the collapse of the healthcare system during the COVID-19 pandemic in China.中国 COVID-19 大流行期间主要慢性疾病和不同年龄患者对医疗体系崩溃的敏感性。
Medicine (Baltimore). 2024 Nov 29;103(48):e40730. doi: 10.1097/MD.0000000000040730.